Skip to search formSkip to main contentSkip to account menu

Gefarnate

Known as: Gefarnate [Chemical/Ingredient], 4,8,12-Tetradecatrienoic acid, 5,9,13-trimethyl-, 3,7-dimethyl-2,6-octadienyl ester, (E,E,E)-, Farnesylacetate, Geranyl 
A water insoluble terpene fatty acid used in the treatment of gastrointestinal ulcers; it facilitates the healing and function of mucosal tissue.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Geranyl farnesylacetate (gefarnate) has been used to stimulate mucin production from goblet cells of patients who have gastritis… 
2002
2002
Purpose. To investigate the ability of gefarnate (geranyl farnesylacetate) to stimulate goblet cell function in the primate eye… 
1998
1998
AIMS The effects of three drugs for the treatment of gastritis and gastric ulcer—gefarnate, ecabet sodium, and troxipide—on… 
1997
1997
The effect of drugs for gastritis and gastric ulcer (ecabet sodium, gefarnate, teprenone, and troxipide) on the secretion of… 
1991
1991
We observed the quantitative estimation of the transmural changes associated with gastric ulcer healing by using endoscopic… 
1983
1983
The effects of cimetidine and gefarnate on endogenous prostacyclin, prostaglandin E2 and thromboxane were studied in vivo in rat… 
1983
1983
The level of endogenous prostacyclin (PGI2), prostaglandin E2 (PGE2) and thromboxane A2 (TXA2) in rat gastric mucosa was… 
1982
1982
Antiulcer effects of geranylgeranylacetone (GGA) on aspirin-induced gastric ulcers in rats were studied, comparing them with… 
1974
1974
SummaryA study to investigate the mechanism of action of gefarnate (treatment: 600 mg. daily by mouth for 30 days) was carried… 
1973
1973
In 68 patients with chronic gastric ulcer treated in an outpatient clinical trial with either carbenoxolone or gefarnate ulcer…